Published • loading... • Updated
FDA's new playbook: Lots of media announcements but not much rulemaking
The agency is using news releases, interviews and op-eds to move faster on vaccines, drugs and food dyes without formal rulemaking.
- Under federal law, the FDA is supposed to avoid major policy announcements in informal settings, but Drug Administration Commissioner Marty Makary has increasingly unveiled changes in op-eds and television interviews, bypassing the Federal Register.
- Robert Kennedy initiated a plan to 'phase out' synthetic food dyes, relying on an 'understanding' with companies rather than formal scientific regulatory documents or public comment periods.
- Critics like Yale University public health expert Susan Mayne argue the agency lacks scientific basis, while former vaccine panel lead Kathryn Edwards warned that bypassing advisory panels reduces transparency.
- Industry pushback remains minimal, as experts suggest companies fear jeopardizing product licensing, though an unnamed drugmaker last month challenged the FDA's legal authority to release confidential drug rejection letters.
- Former FDA chief counsel Dan Troy warned that policies not enshrined in law can be easily undone by future administrations, though signs suggest some companies may soon raise objections with more than two years remaining under Trump.
Insights by Ground AI
12 Articles
12 Articles
The Toronto Star+2 Reposted by 2 other sources
FDA’s new playbook: Lots of media announcements but not much rulemaking
WASHINGTON (AP) — In one of his first major announcements as health secretary, Robert F. Kennedy Jr. called a news conference to unveil a plan to “phase out” synthetic food
·Toronto, Canada
Read Full Article
Coverage Details
Total News Sources12
Leaning Left6Leaning Right0Center5Last UpdatedBias Distribution55% Left
Bias Distribution
- 55% of the sources lean Left
55% Left
L 55%
C 45%
Factuality
To view factuality data please Upgrade to Premium
